Takeda Pharmaceutical
TAK
#482
Rank
HK$371.33 B
Marketcap
HK$111.59
Share price
0.84%
Change (1 day)
6.80%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : HK$38.89 Billion

According to Takeda Pharmaceutical's latest financial reports the company has HK$38.89 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31HK$21.04 B-13.89%
2024-03-31HK$24.44 B-25.01%
2023-03-31HK$32.59 B-42.1%
2022-03-31HK$56.29 B-20.03%
2021-03-31HK$70.39 B49.41%
2020-03-31HK$47.11 B-8.15%
2019-03-31HK$51.29 B85.21%
2018-03-31HK$27.69 B5.43%
2017-03-31HK$26.27 B-31.97%
2016-03-31HK$38.61 B-16.2%
2015-03-31HK$46.08 B-27.94%
2014-03-31HK$63.95 B38.25%
2013-03-31HK$46.25 B7.21%
2012-03-31HK$43.14 B-47.1%
2011-03-31HK$81.56 B11.61%
2010-03-31HK$73.08 B22.62%
2009-03-31HK$59.60 B-53.5%
2008-03-31HK$128.17 B7.33%
2007-03-31HK$119.41 B-3.42%
2006-03-31HK$123.65 B12.19%
2005-03-31HK$110.21 B11.44%
2004-03-31HK$98.89 B30.86%
2003-03-31HK$75.57 B45.76%
2002-03-31HK$51.85 B16.39%
2001-03-31HK$44.54 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
HK$144.44 B 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$81.33 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$116.59 B 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$75.89 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
HK$9.62 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$6.11 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
HK$73.49 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$34.58 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$141.73 B 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA